{{Rsnum
|rsid=11102001
|Gene=EPS8L3
|Chromosome=1
|position=109757069
|Orientation=plus
|ReferenceAllele=C
|MissenseAllele=T
|GMAF=0.14
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=EPS8L3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 14.3 | 85.7
| HCB | 0.0 | 1.5 | 98.5
| JPT | 0.0 | 8.0 | 92.0
| YRI | 19.0 | 51.7 | 29.3
| ASW | 17.5 | 47.4 | 35.1
| CHB | 0.0 | 1.5 | 98.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 15.8 | 84.2
| LWK | 16.4 | 48.2 | 35.5
| MEX | 5.2 | 19.0 | 75.9
| MKK | 11.5 | 53.2 | 35.3
| TSI | 0.0 | 13.9 | 86.1
| HapMapRevision=28
}}
{{PMID|19223546|OA=1
}} rs11102001 is a potential candidate modifier of the effect of HCAs on [[prostate cancer]] risk.

{{GET Evidence
|gene=EPS8L3
|aa_change=Pro356Ser
|aa_change_short=P356S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11102001
|overall_frequency_n=29
|overall_frequency_d=128
|overall_frequency=0.226562
|n_genomes=21
|n_genomes_annotated=0
|n_haplomes=25
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.012
|nblosum100=3
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}